Top Markets
Coin of the day
Anteris Technologies Global Corp. Anteris Technologies Global Corp.

Anteris Technologies Global Corp.

AVR
株式のランク #10272
Anteris Technologies Global Corp. is a structural heart innovator dedicated to... Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
株価
$8.88
最終同期: 2026-08-28
時価総額
$863.29M
変化(1日)
-1.02%
変化(1年)
120.86%
US
取引 Anteris Technologies Global Corp. (AVR)

カテゴリー

Anteris Technologies Global Corp.(AVR)のEPS
2026 時点のEPS TTM: 0
Anteris Technologies Global Corp.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Anteris Technologies Global Corp.のEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS